Sarepta Therapeutics (SRPT) Short Interest Ratio & Short Volume → Wall Street Legend Warns: 'A Strange Day Is Coming to America' (From Chaikin Analytics) (Ad) Free SRPT Stock Alerts $113.33 -10.13 (-8.21%) (As of 05/28/2024 ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends Sarepta Therapeutics Short Interest DataCurrent Short Interest6,560,000 sharesPrevious Short Interest5,690,000 sharesChange Vs. Previous Month+15.29%Dollar Volume Sold Short$869.20 millionShort Interest Ratio7.3 Days to CoverLast Record DateMay 15, 2024Outstanding Shares94,520,000 sharesPercentage of Shares Shorted6.94%Today's Trading Volume2,976,396 sharesAverage Trading Volume1,034,692 sharesToday's Volume Vs. Average288% Short Selling Sarepta Therapeutics ? Sign up to receive the latest short interest report for Sarepta Therapeutics and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartSRPT Short Interest Over TimeSRPT Days to Cover Over TimeSRPT Percentage of Float Shorted Over Time Ad Crypto 101 MediaTech GIANT’s Plans to Revolutionize Crypto…A shocking leak has revealed tech giant Microsoft's plans to add crypto support to future products. If the plans in these leaked internal documents pan out, we could see prices skyrocket for Bitcoin, Ethereum, XRP and MORE… The coupling of gaming and cryptocurrency could absolutely transform digital finance as we know it in 2024. Claim your free seat by clicking here now. Sarepta Therapeutics Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 5/15/20246,560,000 shares $869.20 million +15.3%N/A7.3 $132.50 4/30/20245,690,000 shares $720.70 million +16.8%N/A6.2 $126.66 4/15/20244,870,000 shares $576.17 million +5.9%N/A5.8 $118.31 3/31/20244,600,000 shares $595.52 million -7.4%N/A4.5 $129.46 3/15/20244,970,000 shares $611.56 million +4.0%N/A4.6 $123.05 2/29/20244,780,000 shares $611.36 million -0.6%N/A4 $127.90 Get the Latest News and Ratings for SRPT and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Sarepta Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 2/15/20244,810,000 shares $600.72 million -7.0%N/A4.1 $124.89 1/31/20245,170,000 shares $615.18 million -9.0%N/A4.1 $118.99 1/15/20245,680,000 shares $663.42 million +21.1%N/A3.2 $116.80 12/31/20234,690,000 shares $452.26 million -0.4%N/A2.7 $96.43 12/15/20234,710,000 shares $437.98 million +10.6%N/A2.9 $92.99 11/30/20234,260,000 shares $346.25 million +0.2%N/A2.8 $81.28 11/15/20234,250,000 shares $355.98 million -4.5%N/A2.9 $83.76 10/31/20234,450,000 shares $299.53 million -8.8%N/A3 $67.31 10/15/20234,880,000 shares $575.64 million +1.2%N/A5.4 $117.96 9/30/20234,820,000 shares $584.28 million +6.6%N/A5.2 $121.22 9/15/20234,520,000 shares $535.17 million -2.0%N/A4.6 $118.40 8/31/20234,610,000 shares $557.86 million +4.1%N/A4.3 $121.01 8/15/20234,430,000 shares $505.37 million -0.5%N/A3.8 $114.08 7/31/20234,450,000 shares $482.34 million -9.9%N/A3.2 $108.39 7/15/20234,940,000 shares $532.70 million -1.0%N/A3.5 $107.84 6/30/20234,990,000 shares $571.45 million +9.7%N/A3.3 $114.52 6/15/20234,550,000 shares $598.83 million +2.9%N/A3.1 $131.61 5/31/20234,420,000 shares $546.31 million +17.9%N/A2.8 $123.60 5/15/20233,750,000 shares $589.46 million -8.5%N/A2.2 $157.19 4/30/20234,100,000 shares $503.36 million -8.5%N/A2.8 $122.77 4/15/20234,480,000 shares $549.38 million -5.1%N/A3.1 $122.63 3/31/20234,720,000 shares $650.56 million -13.2%N/A3.4 $137.83 3/15/20235,440,000 shares $791.36 million -32.7%N/A4 $145.47 2/28/20238,080,000 shares $986.81 million +7.0%N/A7.1 $122.13 2/15/20237,550,000 shares $941.64 million +12.4%N/A8.1 $124.72 1/31/20236,720,000 shares $839.80 million +8.9%N/A7.3 $124.97 1/15/20236,170,000 shares $781.74 million -9.8%N/A6.5 $126.70 12/30/20226,840,000 shares $886.33 million -1.0%N/A7.3 $129.58 12/15/20226,910,000 shares $861.33 million -1.0%N/A7.5 $124.65 11/30/20226,980,000 shares $857.21 million -5.0%N/A6.5 $122.81 11/15/20227,350,000 shares $806.15 million -8.6%N/A7.2 $109.68 10/31/20228,040,000 shares $916.72 million +11.1%N/A7.5 $114.02 10/15/20227,240,000 shares $814.14 million -1.4%N/A6.4 $112.45 9/30/20227,340,000 shares $811.36 million +7.6%N/A6.7 $110.54Biggest Prediction of My 50-Year Career on Wall Street (Ad)"Bank Runs Will Get Worse," Expert Warns Man who predicted 2023 bank run has warned 8.4 million Americans to get out of U.S. banks immediately. Move your money into a new vehicle 50 years in the making.Click here to learn more. 9/15/20226,820,000 shares $754.84 million +4.1%N/A6 $110.68 8/31/20226,550,000 shares $716.44 million -4.5%N/A6.7 $109.38 8/15/20226,860,000 shares $748.01 million +34.3%N/A7.2 $109.04 7/31/20225,110,000 shares $474.97 million -4.7%N/A5.5 $92.95 7/15/20225,360,000 shares $448.04 million +2.7%N/A6.8 $83.59 6/30/20225,220,000 shares $391.29 million +4.8%N/A6.7 $74.96 6/15/20224,980,000 shares $321.21 million -0.4%N/A6.7 $64.50 5/31/20225,000,000 shares $364.10 million -2.0%N/A7 $72.82 5/15/20225,100,000 shares $336.45 million +5.6%N/A6.7 $65.97 4/30/20224,830,000 shares $349.31 million -1.2%N/A6.6 $72.32 4/15/20224,890,000 shares $398.29 million -5.4%N/A6.2 $81.45 3/31/20225,170,000 shares $403.88 million -2.5%N/A5.2 $78.12 3/15/20225,300,000 shares $403.70 million -1.1%N/A5.4 $76.17 2/28/20225,360,000 shares $410.63 million -2.2%N/A5.4 $76.61 2/15/20225,480,000 shares $445.80 million -6.8%N/A5.6 $81.35 1/31/20225,880,000 shares $420.83 million +30.1%N/A5.8 $71.57 1/15/20224,520,000 shares $321.37 million -1.3%N/A4.3 $71.10 12/31/20214,580,000 shares $412.43 million -15.0%N/A4.4 $90.05 12/15/20215,390,000 shares $470.71 million -1.1%N/A5.2 $87.33 11/30/20215,450,000 shares $440.41 million +16.5%N/A5.2 $80.81 11/15/20214,680,000 shares $392.56 million +2.0%N/A4.7 $83.88 10/29/20214,590,000 shares $363.21 million -8.8%N/A4.7 $79.13 10/15/20215,030,000 shares $423.48 million -0.2%N/A5.3 $84.19 9/30/20215,040,000 shares $466.10 million -11.0%6.7%6 $92.48 9/15/20215,660,000 shares $475.72 million -3.6%7.5%7.3 $84.05 8/31/20215,870,000 shares $458.56 million -5.0%7.8%7.5 $78.12 8/13/20216,180,000 shares $494.03 million -2.4%8.2%6.7 $79.94 7/30/20216,330,000 shares $429.05 million -2.5%8.3%6 $67.78 7/15/20216,490,000 shares $443.72 million +0.8%8.5%5.9 $68.37 6/30/20216,440,000 shares $500.65 million -3.3%8.5%5.9 $77.74 6/15/20216,660,000 shares $553.71 million -16.7%8.8%5.8 $83.14 5/28/20217,990,000 shares $604.44 million +4.0%10.5%6.9 $75.65 5/14/20217,680,000 shares $556.88 million +8.0%N/A6.6 $72.51 4/30/20217,110,000 shares $507.73 million -2.2%N/A6.3 $71.41 4/15/20217,270,000 shares $533.84 million -0.7%N/A6.3 $73.43 3/31/20217,320,000 shares $535.09 million +7.3%N/A3.5 $73.10 3/15/20216,820,000 shares $589.73 million -6.8%N/A3.3 $86.47 2/26/20217,320,000 shares $624.03 million +8.9%N/A3.6 $85.25 2/12/20216,720,000 shares $609.97 million -13.3%N/A3.6 $90.77 1/29/20217,750,000 shares $698.51 million -4.3%N/A4.1 $90.13 1/15/20218,100,000 shares $728.19 million +14.6%N/A4.6 $89.90 12/31/20207,070,000 shares $1.21 billion -10.6%N/A5 $171.54 12/15/20207,910,000 shares $1.34 billion -9.1%N/A11.3 $169.54 11/30/20208,700,000 shares $1.21 billion +5.2%N/A12.7 $139.15 11/15/20208,270,000 shares $1.17 billion -6.2%N/A11.6 $141.40 10/30/20208,820,000 shares $1.25 billion -0.6%N/A12.1 $141.49 10/15/20208,870,000 shares $1.29 billion -2.9%N/A13.5 $145.12 9/30/20209,130,000 shares $1.28 billion +0.7%N/A13.1 $140.43 9/15/20209,070,000 shares $1.30 billion -4.1%N/A12.5 $142.80 8/31/20209,460,000 shares $1.39 billion -3.2%N/A12 $146.42Biggest Prediction of My 50-Year Career on Wall Street (Ad)"Bank Runs Will Get Worse," Expert Warns Man who predicted 2023 bank run has warned 8.4 million Americans to get out of U.S. banks immediately. Move your money into a new vehicle 50 years in the making.Click here to learn more. 8/14/20209,770,000 shares $1.53 billion -3.0%N/A11.7 $157.00 7/31/202010,070,000 shares $1.55 billion -3.5%N/A11.4 $153.52 7/15/202010,440,000 shares $1.74 billion -2.1%14.1%11.6 $166.76 6/30/202010,660,000 shares $1.73 billion -9.9%14.4%11.7 $162.71 6/15/202011,830,000 shares $1.88 billion +1.4%16.0%12.4 $158.85 5/29/202011,670,000 shares $1.78 billion +1.0%15.8%12 $152.27 5/15/202011,560,000 shares $1.63 billion +0.3%15.6%11.8 $141.25 4/30/202011,530,000 shares $1.36 billion -2.7%15.6%13.2 $117.88 4/15/202011,850,000 shares $1.33 billion -4.6%16.0%13.4 $112.09 3/31/202012,420,000 shares $1.51 billion -1.9%16.8%13.1 $121.53 3/13/202012,659,400 shares $1.38 billion +0.6%17.2%14.5 $108.75 2/28/202012,580,000 shares $1.12 billion -0.3%17.1%11.4 $89.38 2/14/202012,620,000 shares $1.39 billion +0.6%17.9%11.2 $110.38 1/31/202012,540,000 shares $1.42 billion -1.0%17.8%10 $113.63 1/15/202012,660,000 shares $1.57 billion +6.3%17.9%9.6 $123.96 12/31/201911,910,000 shares $1.34 billion -12.4%16.9%9.3 $112.39 SRPT Short Interest - Frequently Asked Questions What is Sarepta Therapeutics' current short interest? Short interest is the volume of Sarepta Therapeutics shares that have been sold short but have not yet been closed out or covered. As of May 15th, traders have sold 6,560,000 shares of SRPT short. Learn More on Sarepta Therapeutics' current short interest. What is a good short interest ratio for Sarepta Therapeutics? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. SRPT shares currently have a short interest ratio of 7.0. Learn More on Sarepta Therapeutics's short interest ratio. Which institutional investors are shorting Sarepta Therapeutics? As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Sarepta Therapeutics: Walleye Trading LLC, Jane Street Group LLC, PEAK6 Investments LLC, Twin Tree Management LP, Concourse Financial Group Securities Inc., Rosalind Advisors Inc., and Simplex Trading LLC. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission. Is Sarepta Therapeutics' short interest increasing or decreasing? Sarepta Therapeutics saw a increase in short interest in May. As of May 15th, there was short interest totaling 6,560,000 shares, an increase of 15.3% from the previous total of 5,690,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does Sarepta Therapeutics' short interest compare to its competitors? Here is how the short interest of companies in the sector of "medical" compare to Sarepta Therapeutics: United Therapeutics Co. (9.14%), Dr. Reddy's Laboratories Limited (0.58%), Viatris Inc. (3.61%), Catalent, Inc. (3.76%), BioMarin Pharmaceutical Inc. (1.97%), BeiGene, Ltd. (1.75%), Elanco Animal Health Incorporated (3.43%), Legend Biotech Co. (7.12%), Cerevel Therapeutics Holdings, Inc. (8.14%), Ascendis Pharma A/S (5.94%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.81 billion), Charter Communications, Inc. ($3.30 billion), Occidental Petroleum Co. ($3.10 billion), General Motors ($2.84 billion), Moderna, Inc. ($2.77 billion), AppLovin Co. ($2.22 billion), Royal Caribbean Cruises Ltd. ($2.22 billion), Coinbase Global, Inc. ($2.16 billion), Tractor Supply ($2.12 billion), and Williams-Sonoma, Inc. ($2.12 billion). View all of the most shorted stocks. What does it mean to sell short Sarepta Therapeutics stock? Short selling SRPT is an investing strategy that aims to generate trading profit from Sarepta Therapeutics as its price is falling. SRPT shares are trading down $10.13 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Sarepta Therapeutics? A short squeeze for Sarepta Therapeutics occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of SRPT, which in turn drives the price of the stock up even further. How often is Sarepta Therapeutics' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including SRPT, twice per month. The most recent reporting period available is May, 15 2024. More Short Interest Resources from MarketBeat Related Companies: UTHR Short Interest RDY Short Interest VTRS Short Interest CTLT Short Interest BMRN Short Interest BGNE Short Interest ELAN Short Interest LEGN Short Interest CERE Short Interest ASND Short Interest Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:SRPT) was last updated on 5/28/2024 by MarketBeat.com Staff From Our PartnersWARNING about the death of the U.S. dollar…Colonial MetalsTech GIANT’s Plans to Revolutionize Crypto…Crypto 101 MediaExposed: 10 CENT Crypto to Explode May 20th?True Market InsidersDigitizing the $11T commodities sector with one tiny stockResource Stock DigestBiggest Prediction of My 50-Year Career on Wall StreetChaikin AnalyticsHe Is Giving Away BitcoinCrypto Swap ProfitsTim Sykes’ Urgent Trade Alert: “Make this move now”Timothy SykesTruth about Trump you’ve never heardPorter & Company Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Sarepta Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.